GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

ClinicalTrials.gov ID: NCT05130255

Public ClinicalTrials.gov record NCT05130255. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 8, 2026, 7:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 1 Trial With GD2-SADA:177Lu-DOTA Drug Complex in Patients With Recurrent or Refractory Metastatic Solid Tumors Known to Express GD2, Including Small Cell Lung Cancer, High Risk Neuroblastoma, Sarcoma and Malignant Melanoma

Study identification

NCT ID: NCT05130255
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Y-mAbs Therapeutics; Industry
Enrollment: 60 participants

Conditions and interventions

Conditions

Interventions

GD2-SADA:177Lu-DOTA Complex Drug

Drug

Eligibility (public fields only)

Age range: 16 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 16, 2022
Primary completion: Feb 28, 2027
Completion: Mar 31, 2027
Last update posted: Oct 1, 2024

2022 – 2027

United States locations

U.S. sites: 8
U.S. states: 8
U.S. cities: 8

Facility	City	State	ZIP	Site status
HonorHealth	Scottsdale	Arizona	85258	Recruiting
City of Hope National Medical Center	Duarte	California	91010	Recruiting
University of Chicago	Chicago	Illinois	60637	Not yet recruiting
Corewell Health-BAMF Health	Grand Rapids	Michigan	49503	Recruiting
Memorial Sloan- Kettering Cancer Center	New York	New York	10065	Recruiting
Case Western Reserve University, Cleveland	Cleveland	Ohio	44106	Recruiting
UPMC Hillman Cancer Center	Pittsburgh	Pennsylvania	15260	Active, not recruiting
University of Wisconsin-Madison	Madison	Wisconsin	53705	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05130255, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 1, 2024 · Synced May 8, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05130255 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →